Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GTLB -23.3%, SEMR -15.2%, SFIX -14%, SEAT -9.5%, SBSW -7%, FERG -4.2%, BTDR -3.4% (guidance), MCRB -2.6%, AKYA -2.3%, NIO -2.1%, DYN -1.2%, WCC -0.8% (guidance)
Other news:
- KOS -6.8% (announces offering of 300 mln of Convertible Senior Notes due 2030)
- TNDM -6.6% (proposes $250 mln of convertible notes)
- ALB -6.6% ($1.75 bln public offering)
- STXS -6.5% (regulatory submissions made for MAGiC catheter)
- MSTR -3.7% (offering $600 mln convertible senior notes)
- HLNE -3.3% (prices offering of 1922322 shares of Class A common stock for gross proceeds of ~$210 million)
- INTA -3% (secondary stock offering)
- BHLB -2% (to sell 10 of its NY branches)
- LIVN -2% (offering $300 mln of convertible notes)
- RVMD -1.7% (files mixed shelf)
- ESLT -1.7% (reports impact on its Q4 financial results due to non-cash expenses)
- NVO -1.7% (reports Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial)
- BBIO -1.4% ($250 mln public offering)
- HUT -1.3% (operations update for February 2024)
Analyst comments:
- CC -2.2% (downgraded to Neutral from Buy at UBS)
- GFS -2% (downgraded to Neutral from Positive at Susquehanna)
- RIO -1.4% (downgraded to Hold from Buy at Liberum)
- WSM -1.1% (downgraded to Hold from Buy at Loop Capital)